-
AstraZeneca Faces Intensified Probe in China as Tax Evasion Amount Grows
01 May 2025 03:36 GMT
British-Swedish pharmaceutical giant AstraZeneca plc is facing increasing scrutiny … -quarter earnings report released Tuesday, AstraZeneca confirmed it had received a …
-
AstraZeneca wins set-aside in Germany
30 Apr 2025 23:19 GMT
… )
A Munich court has granted AstraZeneca’s petition to set aside …
-
AstraZeneca unfolds first DTC TV ad for breast cancer med Truqap
30 Apr 2025 20:53 GMT
… Alison Dziarmaga, head of AstraZeneca’s U.S. breast … morphing into 3D scenery.
AstraZeneca tested multiple concepts for the … rolls out, Dziarmaga said AstraZeneca will continue to “do … Tuesday’s disappointing news, AstraZeneca CEO Pascal Soriot maintained in …
-
Imfinzi approval positions AstraZeneca at forefront of perioperative MIBC
30 Apr 2025 19:45 GMT
The FDA has recently approved AstraZeneca’s Imfinzi (durvalumab) for perioperative …
-
AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China
30 Apr 2025 18:21 GMT
-
AstraZeneca’s Truqap Posts Another Pivotal Disappointment as Phase III Prostate Cancer Study Fails
30 Apr 2025 14:45 GMT
… independent data monitoring committee.
AstraZeneca did not provide specific … media call Tuesday that AstraZeneca still expects the drug … , executive vice president of AstraZeneca’s Oncology Business, said … /PTEN pathway.
AstraZeneca has since been trying to …
-
AstraZeneca's highly touted Truqap flunks another phase 3 trial
30 Apr 2025 13:18 GMT
AstraZeneca has come up short in …
-
AstraZeneca has plenty coming down the pipeline to appease the bears
30 Apr 2025 12:35 GMT
AstraZeneca PLC (LSE:AZN) investors looking … and immunology supports durability.
With AstraZeneca trading at under 14 times …
-
AstraZeneca’s Calquence regimens recommended by CHMP for chronic lymphocytic leukaemia
30 Apr 2025 11:30 GMT
AstraZeneca (AZ) has announced that its …
-
AstraZeneca to scrap trails of Truqap in prostate cancer after interim analysis
30 Apr 2025 11:01 GMT
Cambridge: UK-pharma major AstraZeneca has announced plans of discontinuing …